Amyotrophic-Lateral-Sclerosis-ALS-Information-Page

Amyotrophic Lateral Sclerosis (ALS) Information Page


What research is being done?

NINDS researchers hope to understand the mechanisms that trigger motor neurons to degenerate in ALS, and to find effective approaches to halt the progression leading to cell death.  Different models of the disease are helping scientists study gene mutations and cellular defects in ALS.  NINDS-funded research studies are also looking into how ALS symptoms change over time in people with certain gene mutations.  Other scientists hope to develop biological measures (called biomarkers) that can help to identify the rate of progression of the ALS or the effectiveness of a therapeutic approach.

Information from the National Library of Medicine’s MedlinePlus
Amyotrophic Lateral Sclerosis

×
What research is being done?

NINDS researchers hope to understand the mechanisms that trigger motor neurons to degenerate in ALS, and to find effective approaches to halt the progression leading to cell death.  Different models of the disease are helping scientists study gene mutations and cellular defects in ALS.  NINDS-funded research studies are also looking into how ALS symptoms change over time in people with certain gene mutations.  Other scientists hope to develop biological measures (called biomarkers) that can help to identify the rate of progression of the ALS or the effectiveness of a therapeutic approach.

Information from the National Library of Medicine’s MedlinePlus
Amyotrophic Lateral Sclerosis

NINDS researchers hope to understand the mechanisms that trigger motor neurons to degenerate in ALS, and to find effective approaches to halt the progression leading to cell death.  Different models of the disease are helping scientists study gene mutations and cellular defects in ALS.  NINDS-funded research studies are also looking into how ALS symptoms change over time in people with certain gene mutations.  Other scientists hope to develop biological measures (called biomarkers) that can help to identify the rate of progression of the ALS or the effectiveness of a therapeutic approach.

Information from the National Library of Medicine’s MedlinePlus
Amyotrophic Lateral Sclerosis


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications
1275 K Street, N.W.
Suite 250
Washington, DC 20005
Tel: 202-407-8580
300 Technology Square
Suite 400
Cambridge, MA 02139
Tel: 617-441-7200
5550 West Touhy Avenue
Suite 302
Skokie, IL 60077-3254
Tel: 847-679-3311
National Office - 222 S. Riverside Plaza
Suite 1500
Chicago, IL 60606
Tel: 800-572-1717
4770 Buford Hwy NE
Atlanta, GA 30341
Tel: 800-232-4636
P.O. Box 5755
Berkeley, CA 94705
Tel: 617-545-4882
801 Riverside Drive, Suite 6G
Suite 420
New York, NY 10032
Tel: 212-420-7382; 855-900-2257